Epilepsy GTx
EpilepsyGTx is a late-stage biotech company exploring cutting-edge gene therapies to improve the management of focal refractory epilepsy.
$33M Series A ·
Source: fundraisingfox.com
All 2 rounds ↓Signals
Website registeredJul 25, 2020 (6 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series A | $33M | — | fundraisingfox.com | |
| Seed | undisclosed | — | fundraisingfox.com |
Timeline
- Website created
Team
TN
Teresa Nunes Chief Medical Officer
Investors
Companies like Epilepsy GTx
SSimmunome AIBBeech BiotechSeed · Apr 2026
CClaris Bio$118M Series B+ · Jul 2026
EEurekaBio$40M Series B+ · Mar 2024GGC TherapeuticsSeries A · Sep 2024
MMetabolic Psychiatry Labs
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/epilepsy-gtx (get a free API key).